The Phase III trial will enroll over 300 people with Parkinson's disease, some of whom will receive the cough drug ambroxol. Reading time 3 minutes An important clinical trial for Parkinson’s disease ...

There comes a time each year — it could mid-winter in the brittle cold, when colds and flu are making their rounds, or in the middle of spring, when pollen fills the air — when you just can't stop ...